Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Insomnia Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market is expected to play significant role in the development of demand and improvement due to COVID-19..
Based on the type of product, the global Insomnia Drugs market segmented into
Tablets
Capsules
Based on the end-use, the global Insomnia Drugs market classified into
Adults
Children
Based on geography, the global Insomnia Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Eisai
Merck
Pfizer
Sanofi
Takeda
Astellas
Biocodex
Dainippon Sumitomo
ECR Pharmaceuticals
Fidia Farmaceutici
Flynn Pharma
Johnson & Johnson
Juste
Meda
Pernix Therapeutics
Purdue Pharma
Vanda Pharmaceuticals
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INSOMNIA DRUGS INDUSTRY
2.1 Summary about Insomnia Drugs Industry
2.2 Insomnia Drugs Market Trends
2.2.1 Insomnia Drugs Production & Consumption Trends
2.2.2 Insomnia Drugs Demand Structure Trends
2.3 Insomnia Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Tablets
4.2.2 Capsules
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Adults
4.3.2 Children
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Tablets
5.2.2 Capsules
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Adults
5.3.2 Children
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Tablets
6.2.2 Capsules
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Adults
6.3.2 Children
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Tablets
7.2.2 Capsules
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Adults
7.3.2 Children
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Tablets
8.2.2 Capsules
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Adults
8.3.2 Children
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Tablets
9.2.2 Capsules
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Adults
9.3.2 Children
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Eisai
10.1.2 Merck
10.1.3 Pfizer
10.1.4 Sanofi
10.1.5 Takeda
10.1.6 Astellas
10.1.7 Biocodex
10.1.8 Dainippon Sumitomo
10.1.9 ECR Pharmaceuticals
10.1.10 Fidia Farmaceutici
10.1.11 Flynn Pharma
10.1.12 Johnson & Johnson
10.1.13 Juste
10.1.14 Meda
10.1.15 Pernix Therapeutics
10.1.16 Purdue Pharma
10.1.17 Vanda Pharmaceuticals
10.2 Insomnia Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Eisai
10.2.2 Merck
10.2.3 Pfizer
10.2.4 Sanofi
10.2.5 Takeda
10.2.6 Astellas
10.2.7 Biocodex
10.2.8 Dainippon Sumitomo
10.2.9 ECR Pharmaceuticals
10.2.10 Fidia Farmaceutici
10.2.11 Flynn Pharma
10.2.12 Johnson & Johnson
10.2.13 Juste
10.2.14 Meda
10.2.15 Pernix Therapeutics
10.2.16 Purdue Pharma
10.2.17 Vanda Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
1.Table Insomnia Drugs Product Type Overview
2.Table Insomnia Drugs Product Type Market Share List
3.Table Insomnia Drugs Product Type of Major Players
4.Table Brief Introduction of Eisai
5.Table Brief Introduction of Merck
6.Table Brief Introduction of Pfizer
7.Table Brief Introduction of Sanofi
8.Table Brief Introduction of Takeda
9.Table Brief Introduction of Astellas
10.Table Brief Introduction of Biocodex
11.Table Brief Introduction of Dainippon Sumitomo
12.Table Brief Introduction of ECR Pharmaceuticals
13.Table Brief Introduction of Fidia Farmaceutici
14.Table Brief Introduction of Flynn Pharma
15.Table Brief Introduction of Johnson & Johnson
16.Table Brief Introduction of Juste
17.Table Brief Introduction of Meda
18.Table Brief Introduction of Pernix Therapeutics
19.Table Brief Introduction of Purdue Pharma
20.Table Brief Introduction of Vanda Pharmaceuticals
21.Table Products & Services of Eisai
22.Table Products & Services of Merck
23.Table Products & Services of Pfizer
24.Table Products & Services of Sanofi
25.Table Products & Services of Takeda
26.Table Products & Services of Astellas
27.Table Products & Services of Biocodex
28.Table Products & Services of Dainippon Sumitomo
29.Table Products & Services of ECR Pharmaceuticals
30.Table Products & Services of Fidia Farmaceutici
31.Table Products & Services of Flynn Pharma
32.Table Products & Services of Johnson & Johnson
33.Table Products & Services of Juste
34.Table Products & Services of Meda
35.Table Products & Services of Pernix Therapeutics
36.Table Products & Services of Purdue Pharma
37.Table Products & Services of Vanda Pharmaceuticals
38.Table Market Distribution of Major Players
39.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
40.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
41.Table Global Insomnia Drugs Market Forecast (Million USD) by Region 2021f-2026f
42.Table Global Insomnia Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
43.Table Global Insomnia Drugs Market Forecast (Million USD) by Demand 2021f-2026f
44.Table Global Insomnia Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Insomnia Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Insomnia Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Insomnia Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Insomnia Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Insomnia Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Insomnia Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Insomnia Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Tablets Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Capsules Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Insomnia Drugs Sales Revenue (Million USD) of Eisai 2017-2020e
60.Figure Insomnia Drugs Sales Revenue (Million USD) of Merck 2017-2020e
61.Figure Insomnia Drugs Sales Revenue (Million USD) of Pfizer 2017-2020e
62.Figure Insomnia Drugs Sales Revenue (Million USD) of Sanofi 2017-2020e
63.Figure Insomnia Drugs Sales Revenue (Million USD) of Takeda 2017-2020e
64.Figure Insomnia Drugs Sales Revenue (Million USD) of Astellas 2017-2020e
65.Figure Insomnia Drugs Sales Revenue (Million USD) of Biocodex 2017-2020e
66.Figure Insomnia Drugs Sales Revenue (Million USD) of Dainippon Sumitomo 2017-2020e
67.Figure Insomnia Drugs Sales Revenue (Million USD) of ECR Pharmaceuticals 2017-2020e
68.Figure Insomnia Drugs Sales Revenue (Million USD) of Fidia Farmaceutici 2017-2020e
69.Figure Insomnia Drugs Sales Revenue (Million USD) of Flynn Pharma 2017-2020e
70.Figure Insomnia Drugs Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
71.Figure Insomnia Drugs Sales Revenue (Million USD) of Juste 2017-2020e
72.Figure Insomnia Drugs Sales Revenue (Million USD) of Meda 2017-2020e
73.Figure Insomnia Drugs Sales Revenue (Million USD) of Pernix Therapeutics 2017-2020e
74.Figure Insomnia Drugs Sales Revenue (Million USD) of Purdue Pharma 2017-2020e
75.Figure Insomnia Drugs Sales Revenue (Million USD) of Vanda Pharmaceuticals 2017-2020e
76.